Health and Human Services News and Research

RSS

CDC announces winners of the 2022 REACH Lark Galloway-Gilliam Award for Advancing Health Equity Challenge

The Centers for Disease Control and Prevention (CDC) is pleased to announce two winners of the 2022 REACH Lark Galloway-Gilliam Award for Advancing Health Equity Challenge.

1 Aug 2022

NIH updates its strategic plan for hepatitis B research

The National Institutes of Health has updated its Strategic Plan for NIH Research to Cure Hepatitis B, a roadmap for ending the hepatitis B epidemic, focused on developing a cure as well as improved strategies for vaccination, screening and follow-up care.

1 Aug 2022

New imaging technique reveals subtle details about pathology in a rare eye disease

Using a new imaging technique, researchers from the National Eye Institute have determined that retinal lesions from vitelliform macular dystrophy (VMD) vary by gene mutation.

28 Jul 2022

Winners of NIH Technology Accelerator Challenge for Maternal Health announced

The National Institutes of Health today announced the winners of its NIH Technology Accelerator Challenge (NTAC) for Maternal Health, a prize competition for developers of diagnostic technologies to help improve maternal health around the world.

28 Jul 2022

CDC investigation notice highlights outbreak of Salmonella infections from small turtles purchased online

A CDC investigation notice regarding a multistate outbreak of Salmonella infections has been posted: https://www.cdc.gov/salmonella/stanley-07-22/index.html

27 Jul 2022

Innovative technology reveals new insights into cellular reservoirs of HIV

In a presentation today at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC) and their collaborators described how their use of cutting-edge technology revealed new insights into cellular reservoirs of HIV and what those observations could mean for the next steps in HIV cure research. NIAID is part of the National Institutes of Health.

27 Jul 2022

CDC: Novavax's COVID-19 vaccine can be used as another primary series option for adults

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation that Novavax's COVID-19 vaccine be used as another primary series option for adults ages 18 years and older.

26 Jul 2022

New RT-PCR platform gives results faster than other COVID-19 tests on the market

For more than 30 years, polymerase chain reaction (PCR) has been the gold standard in molecular diagnostic testing, detecting genetic material, such as those from a virus or from human DNA.

25 Jul 2022

Three things about the abortion debate that many people get wrong

In the wake of the Supreme Court's decision to overturn the federal right to abortion, things are more than a little confused.

22 Jul 2022

Novavax COVID-19 vaccine now available in the U.S. to protect against severe disease

The Centers for Disease Control and Prevention (CDC) has recommended that Novavax's COVID-19 vaccine be used as another primary series option for adults in the United States ages 18 years and older.

20 Jul 2022

New vaccine shows promise to fight Lassa virus

Researchers at the University of Texas Medical Branch have achieved success with a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever.

19 Jul 2022

COVID-19 vaccine-boosted neutralizing antibody levels decrease substantially within 3 months

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months, according to new clinical trial data.

19 Jul 2022

New data shows the substantial protection offered by third and fourth COVID-19 vaccine doses

A third and fourth COVID-19 vaccine dose offered substantial protection among adults with healthy immune systems who were eligible to receive them during Omicron variant evolution in early 2022, according to a new MMWR published today.

19 Jul 2022

Cardiovascular mortality has declined over the past two decades, but disparities persist

Research supported by the National Institutes of Health shows that cardiovascular-related deaths have declined over the past two decades, but disparities remain.

19 Jul 2022

Aegis Sciences to commence testing for monkeypox using CDC's orthopoxvirus test

Starting today, Aegis Sciences will begin testing for monkeypox using CDC's orthopoxvirus test, which detects most non-smallpox related orthopoxviruses, including monkeypox virus.

18 Jul 2022

Quest Diagnostics starts testing for monkeypox with a real-time PCR test

Starting today, Quest Diagnostics will begin testing for monkeypox. The company has developed a real-time polymerase chain reaction (PCR) test that uses patient swab specimens to qualitatively detect non-variola orthpoxviruses and monkeypox virus DNA.

15 Jul 2022

KHN’s ‘What the Health?’: Life after ‘Roe’ is … confusing

The Supreme Court's decision overturning the federal constitutional right to abortion has left confusion in its wake.

14 Jul 2022

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

The COVID-19 pandemic pushed back years of progress made in combating antimicrobial resistance (AR) in the United States.

14 Jul 2022

A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision does not improve sufficiently, gives results similar to starting off with the higher-priced drug.

14 Jul 2022

Early treatment with interferons could mitigate severe COVID-19 in people with specific genetic factors

Researchers from the National Cancer Institute, part of the National Institutes of Health, and their collaborators have discovered that people of European and African ancestries who were hospitalized for COVID-19 are more likely to carry a particular combination of genetic variants in a gene known as OAS1 than patients with mild disease who were not hospitalized.

14 Jul 2022

Health and Human Services News and Research

CDC announces winners of the 2022 REACH Lark Galloway-Gilliam Award for Advancing Health Equity Challenge

NIH updates its strategic plan for hepatitis B research

New imaging technique reveals subtle details about pathology in a rare eye disease

Winners of NIH Technology Accelerator Challenge for Maternal Health announced

CDC investigation notice highlights outbreak of Salmonella infections from small turtles purchased online

Innovative technology reveals new insights into cellular reservoirs of HIV

CDC: Novavax's COVID-19 vaccine can be used as another primary series option for adults

New RT-PCR platform gives results faster than other COVID-19 tests on the market

Three things about the abortion debate that many people get wrong

Novavax COVID-19 vaccine now available in the U.S. to protect against severe disease

New vaccine shows promise to fight Lassa virus

COVID-19 vaccine-boosted neutralizing antibody levels decrease substantially within 3 months

New data shows the substantial protection offered by third and fourth COVID-19 vaccine doses

Cardiovascular mortality has declined over the past two decades, but disparities persist

Aegis Sciences to commence testing for monkeypox using CDC's orthopoxvirus test

Quest Diagnostics starts testing for monkeypox with a real-time PCR test

KHN’s ‘What the Health?’: Life after ‘Roe’ is … confusing

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

Early treatment with interferons could mitigate severe COVID-19 in people with specific genetic factors

Event guide: 6th Operationalize Expanded Access Programs Summit East eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News